The original volume of the tumor was significantly reduced after 2 rounds of anti-HER-2-targeted therapy and chemotherapy combined with internal administration of TCM, and the nausea, vomiting, bone marrow suppression, and loss of appetite in the course of targeted therapy and chemotherapy were significantly reduced. This evidence concerns the gene ERBB2 and neoplasm.